Naomi R. Florea

Naomi R. Florea, PharmD

Vice Chair of Innovation
Associate Professor
Titus Family Department of Clinical Pharmacy

Clinical Pharmacy

Research Topics

Research interests range from the pharmacokinetics/pharmacodynamics of anti-infectives to the impact of pharmacist run medical clinics in underserved areas.

Contact Information

  • florea@usc.edu
  • 1985 Zonal Avenue
    Los Angeles, California 90033
  • PSC 604
  • 323-442-2680
  • 323-442-1395

Education

Doctor of Pharmacy
University of Southern California School of Pharmacy

Infectious Diseases Pharmacotherapy Research Fellowship
Center for Anti-Infective Research and Development, Hartford Hospital

Naomi R. Florea

Biography

Dr. Florea graduated from the University of Southern California School of Pharmacy and completed a post-graduate Infectious Diseases Pharmacotherapy Research Fellowship at the Center for Anti-Infective Research and Development in Hartford, Connecticut. Dr. Florea joined the faculty at Loma Linda University School of Pharmacy in 2003, where she was involved in didactic and experiential course education, clinical practice, research, and international medical outreach. In 2012, Dr. Florea was appointed as Chair of the Department of Experiential and Continuing Education at Loma Linda University. During her tenure there, Dr. Florea received numerous awards including Professor and Preceptor of the Year, Spiritual Wholeness, and the prestigious Humanitarian Service Award. Dr. Florea joined the faculty at the University of Southern California School of Pharmacy in October 2015, as Vice Chair of Innovation and Associate Professor in the Titus Family Department of Clinical Pharmacy.

Selected Projects/Publications

Florea NR, Kuti JL, Quintiliani R. Voriconazole (Vfend®):  A Novel Azole Antifungal.  Formulary.  2002;37(8):387-398.

Florea NR, Maglio D, ,Nicolau DP.  Pleconaril:  A Novel Antipicornaviral Agent.  Pharmacotherapy.  2003;23(3):339-348. 

Florea NR, Kuti JL, Nightingale CH, Nicolau DP.  Treatment of Clostridium Difficile-Associated Disease (CDAD).  Connecticut Medicine.  2003;67(3):153-155 

Florea NR, Kotapati S, Kuti JL, Nightingale CH, Nicolau DP. Cost Analysis of Continuous versus Intermittent Infusion Piperacillin/Tazobactam:  A Time Motion Study. American Journal of Health-Systems Pharmacists.  Am J Health-Syst Pharm.  2003;60.

Florea NR, Capitano C, Nightingale CH, Hull D, Nicolau DP.  Evaluation of beneficial pharmacokinetic interaction between cyclosporine and itraconazole in renal transplant recipients.  Transplantation Proceedings.  2003;35:2873-2877.

Kuti JL, Florea NR, Nightingale CH, Nicolau DP.  Pharmacodynamics of Meropenem and Imipenem Against Enterobacteriaceae, Acinetobacter baumanii and Pseudomonas Aeruginosa.  Pharmacotherapy.  2004;24(1):8-15.

Florea NR, Tessier P, Zhang C. Nightingale CH, Nicolau DP.   Bronchopulmonary pharmacokinetic and pharmacodynamic profile of moxifloxacin and levofloxacin:  an in-vitro model of resistance.  Antimicrobial Agents and Chemotherapy. 2004;48(4):1215-1221. 

Florea NR, Nightingale CH. Pharmacodynamics of Antibiotic Use In Animal Food Production.  Diagn. Microbiol. Infect. Dis. 2004;49(2):105-108.

Florea NR, Kuti JL, Nightingale CH, Nicolau DP.  Prevalence and Characteristics of Intravenous to Oral Conversion Programs for Anti-Infectives in the United States. Hospital Pharmacy  2004;39(11):1069-1075.

Florea NR, Park JA.  Antimicrobial Efficacy Review.  Infectious Diseases Special Edition. 2005. 

Heidari S, Florea NR.  Community Acquired Methicillin Resistant Staphylococcus Aureus.  California Pharmacist Association (CPHA) Journal Special Edition on Community Acquired Infections.  May 2008. 

Heidari S, Florea NR.  Managment of Community Acquired Pneumonia In An Era of Emerging Resistance.  Continuing Education. A California Pharmacist Association (CPHA) Journal Special Edition on Community Acquire Infections. Vol. LV, No. 4 Fall 2008. Pp. 48-54

Heidari S, Florea NR.  Managment of Community Acquired Pneumonia In An Era of Emerging Resistance.  Continuing Education TEST. A California Pharmacist Association (CPHA) Journal Special Edition on Community Acquire Infections. November 2008 Vol. LV, No. 4 Fall 2008. Page 55.

Beshay S, Rivera G, Balthasar J, Florea NR. Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy.  International Journal of Pharmaceutical Compounding. January/February 2015. Vol. 19;No. 1. Pages 6-12.

Beshay S, Rivera G, Balthasar J, Florea NR. Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management.  International Journal of Pharmaceutical Compounding. July/August 2015-Volume 19, Number 4.

Quintiliani R,  Florea NR, Nightingale CH.  Current Issues Involved in the Treatment of Community Acquired Pneumonia.  In: Community Acquired Respiratory Tract Infections, Editors: C.H. Nightingale, P.G. Ambrose, T. File. Marcel Dekker, Inc. NY, NY.